= Solution
\b[Location determines access to substrates, cofactors and transport routes; identical catalytic potential can therefore serve different physiological functions in different compartments.] In carbohydrate metabolism, the <plasma membrane>, <mitochondrion> and <endoplasmic reticulum> are selective barriers, not merely containers. A soluble enzyme cannot use a metabolite efficiently if that metabolite cannot reach its compartment, while transporter abundance matters chiefly when the transporter is in the appropriate membrane.
Most <glycolysis> occurs in the <cytosol>, whereas <pyruvate dehydrogenase complex> and much oxidative metabolism occur in the mitochondrial matrix. Pyruvate entry therefore links cytosolic <glucose> breakdown to mitochondrial oxidation. Cytosolic <NADH> does not freely cross the inner mitochondrial membrane: the <malate-aspartate shuttle> and <glycerol phosphate shuttle> transfer reducing equivalents through different routes. Their operation affects the energetic outcome of <glucose> use. In <gluconeogenesis>, mitochondrial <pyruvate carboxylase> produces <oxaloacetate>, but oxaloacetate itself does not freely cross that membrane. Conversion into transportable intermediates, or formation of phosphoenolpyruvate in the appropriate compartment, allows carbon to reach cytosolic steps. Enzyme localization thus imposes an obligatory transport and redox problem, not just an extra reaction label.
At the final step of hepatic <glucose> production, the catalytic site of <glucose-6-phosphatase> faces the endoplasmic-reticulum lumen. <Glucose-6-phosphate> must reach it through the associated transport system. Hydrolysis makes free <glucose> available for export, whereas the phosphate ester is largely retained by membranes. Muscle can mobilize cytosolic <glycogen> to glucose-6-phosphate for its own <glycolysis>, but lacks the hepatic glucose-6-phosphatase system needed for substantial release of that carbon as free blood <glucose>. Tissue function therefore depends on both enzyme expression and the membrane machinery surrounding the enzyme.
Transporter traffic changes function without waiting for new <protein> synthesis. In resting muscle and adipose cells, much <GLUT4> resides in intracellular vesicles. <Insulin> signalling promotes its delivery to the cell surface and increases <glucose> uptake; internalization subsequently reduces surface transport capacity. Classical membrane-fractionation and transport-site measurements supported redistribution from an intracellular pool to the plasma membrane.<Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane by S. W. Cushman and others>[Cushman and Wardzala, 1980, pp. 4758–4762, intracellular and plasma-membrane transport-site distributions]{ref} Fractionation requires compartment markers, and surface labelling or microscopy provides an independent check: altered fraction recovery alone could otherwise mimic redistribution. Total cellular <GLUT4> is not an adequate proxy for surface uptake capacity.
Polarity provides another example. In intestinal epithelial cells, apical <SGLT1> uses the sodium electrochemical gradient to take up <glucose>, whereas basolateral <GLUT2> enables exit towards the circulation. Basolateral <sodium-potassium ATPase> maintains the sodium gradient. Misplacing a transporter can disrupt vectorial absorption despite normal intrinsic transport activity. Glycogen-associated regulatory enzymes similarly gain access to a localized substrate pool. These examples show why localization should be tested with activity and transport measurements as well as images. \b[Compartmentation creates direction, regulation and tissue specialization, while requiring transporters that connect the separated reactions.]
Back to article page
